44 min listen
Too much for Medicare?, hot, hot housing and America’s ammo shortage
FromThe Exchange
ratings:
Length:
45 minutes
Released:
Jun 29, 2021
Format:
Podcast episode
Description
Biogen’s new Alzheimer’s Disease drug is being hailed as a medical breakthrough.
But could its $56,000 per year price tag be too much for Medicare to handle? We’ll debate.
Plus, home prices just posted their biggest gain in the history of the Case-Shiller Index, up 15% in April.
Can the hot housing market keep rolling? And are investors actually driving up prices? We’ll ask Coldwell Banker’s CEO.
And, record gun sales are leading to an ammunition shortage across America. Can the manufacturers catch up to demand? We’ll explore.
But could its $56,000 per year price tag be too much for Medicare to handle? We’ll debate.
Plus, home prices just posted their biggest gain in the history of the Case-Shiller Index, up 15% in April.
Can the hot housing market keep rolling? And are investors actually driving up prices? We’ll ask Coldwell Banker’s CEO.
And, record gun sales are leading to an ammunition shortage across America. Can the manufacturers catch up to demand? We’ll explore.
Released:
Jun 29, 2021
Format:
Podcast episode
More Episodes from The Exchange
Rate debate, un-welcoming party?, and Credit Suisse bets on bubbles: We’re just an hour away from getting the minutes from the latest Fed meeting, where the FOMC started to sound hawkish. We’ll debate which way rates go next. Plus, Chinese stocks are selling off again today. Did U.S. investors overestimate how committed China was to capitalism? We’ll explore how ‘welcoming’ (or not) it’s becoming to outside investors. And, in today’s Rapid Fire: more people are paying with crypto, some people are working less but getting paid the same, and Credit Suisse is betting more people will begin drinking hard seltzer. by The Exchange